Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 105 results.
User Information
Export Records
  1. 1.   Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection
  2. Tsou, Pei-Suen; Ali, Ramadan A; Lu, Chenyang; Sule, Gautam; Carmona-Rivera, Carmelo; Lucotti, Serena; Ikari, Yuzo; Wu, Qi; Campbell, Phillip; Gurrea-Rubio, Mikel; Maeda, Kohei; Fox, Sharon E; Brodie, William D; Mattichak, Megan N; Foster, Caroline; Tambralli, Ajay; Yalavarthi, Srilakshmi; Amin, M Asif; Kmetova, Katarina; Mazetto Fonseca, Bruna; Chong, Emily; Zuo, Yu; Maile, Michael; Imberti, Luisa; Caruso, Arnaldo; Caccuri, Francesca; Quaresima, Virginia; Sottini, Alessandra; Kuhns,Douglas; Fink,Danielle; Castagnoli, Riccardo; Delmonte, Ottavia; Kenney, Heather; Zhang, Yu; Magliocco, Mary; Su, Helen C; Notarangelo, Luigi D; Zemans, Rachel L; Mao-Draayer, Yang; Matei, Irina; Salvatore, Mirella; Lyden, David C; Kanthi, Yogendra; Kaplan, Mariana J; Knight, Jason S; Fox, David A
  3. JCI Insight. 2025, Apr 01;
  1. 2.   Prior SARS-Cov-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster
  2. Wachter, Brianna T; Xu, Qin; Shi, Lihong; Burbelo, Peter D; Myint-Hpu, Kathy; Schwartzberg, Pamela L; Rehman,Tauseef; Dewar,Robin; Boswell, Kristin L; Koup, Richard A; Oguz, Cihan; Imberti, Luisa; Bellusci, Lorenza; Pourhashemi, Sara; Khurana, Surender; Manthiram, Kalpana; Notarangelo, Luigi D; Delmonte, Ottavia M
  3. The journal of Allergy and Clinical Immunology. . 2025, Mar 03;
  1. 3.   Examining the bias-efficiency tradeoff from incorporation of nonconcurrent controls in platform trials: A simulation study example from the adaptive COVID-19 treatment trial
  2. Bonnett,Tyler; Potter, Gail E; Dodd, Lori E
  3. Clinical Trials (London, England). 2025, Feb 08; 17407745251313928.
  1. 4.   Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms
  2. Brandstetter Figueroa, Elisabeth; Frosch, Anne E P; Burrack, Kristina S; Dileepan, Gayathri; Goldsmith, Rachael; Harris, Morgan; Ikeogu, Nwando; Jibrell, Hodan; Thayalan, Sangeitha; Dewar,Robin; Shenoy, Chetan; Sereti, Irini; Baker, Jason V
  3. Open Forum Infectious Diseases. 2025, Feb; 12(2): ofaf048.
  1. 5.   Use of mobile phones to collect data on COVID-19: phone access and participation rates, in Rakai, Uganda
  2. Ssekubugu, Robert; Ndyanabo, Anthony; Makumbi, Fredrick; Ekström, Anna Mia; Beres, Laura; Nalwoga Kigozi, Grace; Nakawooya, Hadijja; Ssekasanvu, Joseph; Wawer, Maria J; Nalugoda, Fred; Sewankambo, Nelson; Ssempijja,Victor; Nantume, Betty; Serwadda, David; Kigozi, Godfrey; Gray, Ronald H; Chang, Larry W; Grabowski, M Kate; Nordenstedt, Helena; Kagaayi, Joseph
  3. Global Health Action. 2024, Dec 31; 17(1): 2419160.
  1. 6.   Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA
  2. Maiti,Atanu; Matsuo,Hiroshi
  3. Biomolecules. 2024, Nov 30; 14(12):
  1. 7.   Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials
  2. Guerra-de-Blas, Paola Del Carmen; Marines-Price, Rubria; Milman, Olga; Deal,Danae; Marchand,Jon; Linton,Jessica; Meger, Sue; Rule, John; Holland, Thomas L; Kitonsa, Jonathan; Delph, Yvette
  3. Journal of Clinical and Translational Science. 2024, Oct 15; 8(1): e157.
  1. 8.   Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
  2. Fong, Youyi; Dang, Lauren; Zhang, Bo; Fintzi, Jonathan; Chen, Shiyu; Wang, Jing; Rouphael, Nadine G; Branche, Angela R; Diemert, David J; Falsey, Ann R; Losada, Cecilia; Baden, Lindsey R; Frey, Sharon E; Whitaker, Jennifer A; Little, Susan J; Kamidani, Satoshi; Walter, Emmanuel B; Novak, Richard M; Rupp, Richard; Jackson, Lisa A; Yu, Chenchen; Magaret, Craig A; Molitor, Cindy; Borate, Bhavesh; Babu, Tara M; Kottkamp, Angelica C; Luetkemeyer, Anne F; Immergluck, Lilly C; Presti, Rachel M; Bäcker, Martín; Winokur, Patricia L; Mahgoub, Siham M; Goepfert, Paul A; Fusco, Dahlene N; Atmar, Robert L; Posavad, Christine M; Mu, Jinjian; Makowski, Mat; Makhene, Mamodikoe K; Nayak, Seema U; Roberts, Paul C; Follmann, Dean; Gilbert, Peter B
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2024, Sep 26;
  1. 9.   SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir
  2. Singh, Kanal; Rubenstein,Kevin; Callier,Viviane; Shaw-Saliba, Katy; Rupert,Adam; Dewar,Robin; Laverdure,Sylvain; Highbarger,Helene; Lallemand,Perrine; Huang, Meei-Li; Jerome, Keith R; Sampoleo, Reigran; Mills, Margaret G; Greninger, Alexander L; Juneja, Kavita; Porter, Danielle; Benson, Constance A; Dempsey, Walla; El Sahly, Hana M; Focht, Chris; Jilg, Nikolaus; Paules, Catharine I; Rapaka, Rekha R; Uyeki, Timothy M; Lane, H Clifford; Beigel, John; Dodd, Lori E
  3. The Journal of Infectious Diseases. 2024, Sep 23; 230(3): 624-634.
  1. 10.   Impact of baseline SARS-CoV-2 load in plasma and upper airways on the incidence of acute extrapulmonary complications of COVID-19: a multicentric, prospective, cohort study
  2. Jensen, Tomas O; Harper, Katrina; Gupta, Shaili; Liu, Sean T; Dharan, Nila J; Baker, Jason V; Pett, Sarah L; Shaw-Saliba, Kathryn; Esmail, Aliasgar; Ho, Minh Q; Almasri, Eyad; Dewar,Robin; Lundgren, Jens; Vock, David M
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2024, Sep 13;
  1. 11.   Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19
  2. Reilly, Cavan; Mylonakis, Eleftherios; Dewar,Robin; Young, Barnaby; Nordwall, Jacqueline; Bhagani, Sanjay; Chia, Po-Ying; Davis, Ruby; Files, Clark; Ginde, Adit A; Hatlen, Timothy; Helleberg, Marie; Hayanga, Awori; Jensen, Tomas O; Jain, Mamta K; Kalomenidis, Ioannis; Kim, Kami; Lallemand,Perrine; Lindegaard, Birgitte; Menon, Anupama; Ognenovska, Katherine; Poulakou, Garyfallia; Thorup Røge, Birgit; Rogers, Angela J; Shaw-Saliba, Katy; Sandkovsky, Uriel; Trautner, Barbara W; Vasudeva, Shikha S; Vekstein, Andrew; Viens, Kimberley; Wyncoll, James; DuChateau, Brian; Zhang, Zhenxing; Wu, Shujiang; Babiker, Abdel G; Davey, Victoria; Gelijns, Annetine; Higgs, Elizabeth; Kan, Virginia; Lundgren, Jens; Matthews, Gail V; Lane, H Cliff
  3. The Journal of Infectious Diseases. 2024, Sep 12;
  1. 12.   MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus
  2. DeBarros, Kenya; Khan, Mahfuz; Coleman, Morgan; Bond, Vincent C; Floyd, Virginia; Gbodossou, Erick; Diop, Amad; Krumpe,Lauren; O'Keefe,Barry; Powell, Michael D
  3. Viruses. 2024, Sep 07; 16(9):
  1. 13.   Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019
  2. Jilg, Nikolaus; Giganti, Mark J; Chew, Kara W; Shaw-Saliba, Katy; Ritz, Justin; Moser, Carlee; Evering, Teresa H; Daar, Eric S; Eron, Joseph J; Currier, Judith S; Hughes, Michael D; Lane, H Cliff; Dewar,Robin; Smith, Davey M; Li, Jonathan Z
  3. Clinical Infectious diseases : an official publication of the Infectious Diseases Society of America. 2024, Jul 17;
  1. 14.   Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19
  2. Kanth, Shreya M; Huapaya, Julio A; Gairhe, Salina; Wang, Honghui; Tian, Xin; Demirkale, Cumhur Y; Hou, Chunyan; Ma, Junfeng; Kuhns,Doug; Fink,Dani; Malayeri, Ashkan; Turkbey, Evrim; Harmon, Stephanie A; Chen, Marcus Y; Regenold, David; Lynch, Nicolas F; Ramelli, Sabrina; Li, Willy; Krack, Janell; Kuruppu, Janaki; Lionakis, Michail S; Strich, Jeffrey R; Davey, Richard; Childs, Richard; Chertow, Daniel S; Kovacs, Joseph A; Parizi, Parizad Torabi-; Suffredini, Anthony F
  3. Cell Reports. Medicine. 2024, Jul 16; 5(7): 101642.
  1. 15.   "A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination"
  2. Khalid, Muhammad B; Zektser, Ellen; Chu,Eric; Li, Min; Utoh, Joanna; Ryan, Patrick; Loving, Hanna S; Harb, Roa; Kattappuram, Robbie; Chatman, Lindsay; Hartono, Stella; Claudio-Etienne, Estefania; Sun, Guangping; Feener, Edward P; Li, Zhongbo; Lai, Samuel K; Le, Quang; Schwartz, Lawrence B; Lyons, Jonathan J; Komarow, Hirsh; Zhou, Zhao-Hua; Raza, Haniya; Pao, Maryland; Laky, Karen; Holland, Steven M; Brittain, Erica; Frischmeyer-Guerrerio, Pamela A
  3. The journal of Allergy and Clinical Immunology. . 2024, Jun; 153(6): 1634-1646.
  1. 16.   Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
  2. Hartmann, Jordan A; Cardoso, Marcella R; Talarico, Maria Cecilia Ramiro; Kenney, Devin J; Leone, Madison R; Reese, Dagny C; Turcinovic, Jacquelyn; O'Connell, Aoife K; Gertje, Hans P; Marino, Caitlin; Ojeda, Pedro E; De Paula, Erich V; Orsi, Fernanda A; Velloso, Licio Augusto; Cafiero, Thomas R; Connor, John H; Ploss, Alexander; Hoelzemer, Angelique; Carrington,Mary; Barczak, Amy K; Crossland, Nicholas A; Douam, Florian; Boucau, Julie; Garcia-Beltran, Wilfredo F
  3. Cell. 2024, Apr 11;
  1. 17.   COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials
  2. Sherman, Amy; Tuan, Jessica; Cantos, Valeria D; Adeyiga, Oladunni; Mahoney, Scott; Ortega-Villa, Ana M; Tillman,Amy; Whitaker, Jennifer; Woodward Davis, Amanda S; Leav, Brett; Hirsch, Ian; Sadoff, Jerald; Dunkle, Lisa M; Gilbert, Peter B; Janes, Holly E; Kublin, James G; Goepfert, Paul A; Kotloff, Karen; Rouphael, Nadine; Falsey, Ann R; El Sahly, Hana M; Sobieszczyk, Magdalena E; Huang, Yunda; Neuzil, Kathleen M; Corey, Lawrence; Grinsztejn, Beatriz; Gray, Glenda; Nason, Martha; Baden, Lindsey R; Gay, Cynthia L
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2024, Apr 10;
  1. 18.   SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali
  2. Sylvain, Laverdure; Donatien, Kazadi; Kadidia, Kone; Viviane, Callier; Djeneba, Dabitao; Dehkontee, Dennis; Cherif, Haidara Mory; Sally, Hunsberger; Tshiani Mbaya,Olivier; Renee, Ridzon; Irini, Sereti; Katy, Shaw-Saliba
  3. International Journal of Infectious Diseases : IJID : official publication of the International Society for Infectious Diseases. 2024, Feb 26; 106985.
  1. 19.   Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial
  2. Alipanah-Lechner, Narges; Hurst-Hopf, James; Delucchi, Kevin; Swigart, Lamorna; Willmore, Andrew; LaCombe, Benjamin; Dewar,Robin; Lane, H Clifford; Lallemand, Perrine; Liu, Kathleen D; Esserman, Laura; Matthay, Michael A; Calfee, Carolyn S
  3. Critical Care (London, England). 2024, Feb 21; 28(1): 56.
  1. 20.   Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
  2. Aggarwal, Neil R; Nordwall, Jacquie; Braun, Dominique L; Chung, Lucy; Coslet, Jordan; Der, Tatyana; Eriobu, Nnakelu; Ginde, Adit A; Hayanga, Awori J; Highbarger, Helene; Holodniy, Mark; Horcajada, Juan P; Jain, Mamta K; Kim, Kami; Laverdure, Sylvain; Lundgren, Jens; Natarajan, Ven; Nguyen, Hien H; Pett, Sarah L; Phillips, Andrew; Poulakou, Garyphallia; Price, David A; Robinson, Philip; Rogers, Angela J; Sandkovsky, Uriel; Shaw-Saliba, Katy; Sturek, Jeffrey M; Trautner, Barbara W; Waters, Michael; Reilly, Cavan
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2024, Feb 20;
  1. 21.   Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine
  2. Follmann, Dean; Mateja, Allyson; Fay, Michael P; Magaret, Craig A; Huang, Yunda; Fong, Youyi; Angier, Heather; Nason, Martha; Gay, Cynthia L; Kotloff, Karen; Woo, Wayne; Cho, Iksung; Dunkle, Lisa M
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2024, Feb 19;
  1. 22.   Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5
  2. Wang, Zhantong; Zhang, Baoshan; Ou, Li; Qiu, Qi; Wang, Lingshu; Bylund, Tatsiana; Kong, Wing-Pui; Shi, Wei; Tsybovsky,Yaroslav; Wu, Lingyuan; Zhou, Qiong; Chaudhary, Ridhi; Choe, Misook; Dickey, Thayne H; El Anbari, Mohammed; Olia, Adam S; Rawi, Reda; Teng, I-Ting; Wang, Danyi; Wang, Shuishu; Tolia, Niraj H; Zhou, Tongqing; Kwong, Peter D
  3. Vaccines. 2023, Dec 28; 12(1):
  1. 23.   Impact of Surge Strain and Pandemic Progression on Prognostication by an Established COVID-19-Specific Severity Score
  2. Yek, Christina; Wang,Jing; Fintzi, Jonathan; Mancera, Alex G; Keller, Michael B; Warner, Sarah; Kadri, Sameer S
  3. Critical Care Explorations. 2023, Dec; 5(12): e1021.
  1. 24.   SARS-CoV-2 papain-like protease (PLpro) plays multiple roles in regulating cellular proteins in the endoplasmic reticulum
  2. Yang,Mei; Mariano,Jennifer; Su, Rebecca; Smith, Christopher E; Das,Sudipto; Gill, Catherine; Andresson,Thorkell; Loncarek,Jadranka; Tsai,Yien Che; Weissman,Allan
  3. The Journal of Biological Chemistry. 2023, Dec; 299(12): 105346.
  1. 25.   Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
  2. Jensen, Tomas O; Grandits, Greg A; Jain, Mamta K; Murray, Thomas A; Grund, Birgit; Shaw-Saliba, Kathryn; Matthay, Michael A; Abassi, Mahsa; Ardelt, Magdalena; Baker, Jason V; Chen, Peter; Dewar, Robin L; Goodman, Anna L; Hatlen, Timothy J; Highbarger, Helene C; Holodniy, Mark; Lallemand, Perrine; Laverdure,Sylvain; Leshnower, Bradley G; Looney, David; Moschopoulos, Charalampos D; Mugerwa, Henry; Murray, Daniel D; Mylonakis, Eleftherios; Nagy-Agren, Stephanie; Rehman, M Tauseef; Rupert, Adam; Stevens, Randy A; Turville, Stuart; Weintrob, Amy; Wick, Katherine; Lundgren, Jens; Ko, Emily R
  3. The Journal of Infectious Diseases. 2023, Nov 09;
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel